DGAP-PVR: Bayerische Motoren Werke AG: Release according to

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Sep 30, 2014 at 12:15 PM

DGAP-PVR: Bayerische Motoren Werke AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Bayerische Motoren Werke AG 30.09.2014 18:00 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- On 30 September 2014 we received the following notifications pursuant to Article 21 Section 1 WpHG: 'Following a review, conducted in close collaboration with the Bundesanstalt fÃ¼r Finanzdienstleistungsaufsicht (BaFin), of the way BlackRock has interpreted its voting rights disclosure obligations under German law, BlackRock entities are filing today a statement representing their holdings as at the settlement date of 25 September 2014 in Bayerische Motoren Werke Aktiengesellschaft. The statement does not reflect a change in BlackRock's current holdings of voting rights. The statement simply updates information currently in the market regarding BlackRock's holdings in Bayerische Motoren Werke Aktiengesellschaft. Further, the statement does not signify any change in investment strategies pursued. Also, BlackRock issues a press release detailing the BlackRock group entities and their respective voting rights applicable to Bayerische Motoren Werke Aktiengesellschaft and other relevant German issuers on http://www.blackrock.com/corporate/en-gb/news...s-releases and on Bloomberg. VOTING RIGHTS DISCLOSURE 1. BlackRock, Inc. Section 21, 22 BlackRock, Inc., New York, NY, U.S.A., hereby informs you pursuant to Sec. 21 para. 1 WpHG that its share in the voting rights of Bayerische Motoren Werke Aktiengesellschaft (ISIN DE0005190003) on 25 September 2014 amounts to 3.44% (this corresponds to 20,698,662 out of a total of 601,995,196 voting rights (the 'Total Voting Rights')). 1.64% of the Total Voting Rights (this corresponds to 9,855,045 voting rights) are to be attributed to BlackRock, Inc. pursuant to Sec. 22 para. 1 sentence 1 No. 1 WpHG. 0.001% of the Total Voting Rights (this corresponds to 5,975 voting rights) are to be attributed to BlackRock, Inc. pursuant to Sec. 22 para. 1 sentence 1 No. 2 in connection with sentence 2 WpHG. 1.61% of the Total Voting Rights (this corresponds to 9,689,544 voting rights) are to be attributed to BlackRock, Inc. pursuant to Sec. 22 para. 1 sentence 1 No. 6 in connection with sentence 2 WpHG. 0.19% of the Total Voting Rights (this corresponds to 1,154,073 voting rights) are to be attributed pursuant to Sec. 22 para. 1 sentence 1 No. 1 WpHG as well as pursuant to Sec. 22 para. 1 sentence 1 No. 6 in connection with sentence 2 WpHG. 2. BlackRock Holdco 2, Inc. Section 21, 22 BlackRock Holdco 2, Inc., Wilmington, DE, U.S.A., hereby informs you pursuant to Sec. 21 para. 1 WpHG that its share in the voting rights of Bayerische Motoren Werke Aktiengesellschaft (ISIN DE0005190003) on 25 September 2014 amounts to 3.37% (this corresponds to 20,309,309 out of a total of 601,995,196 voting rights (the 'Total Voting Rights')). 1.64% of the Total Voting Rights (this corresponds to 9,855,045 voting rights) are to be attributed to BlackRock Holdco 2, Inc. pursuant to Sec. 22 para. 1 sentence 1 No. 1 WpHG. 0.001% of the Total Voting Rights (this corresponds to 5,975 voting rights) are to be attributed to BlackRock Holdco 2, Inc. pursuant to Sec. 22 para. 1 sentence 1 No. 2 in connection with sentence 2 WpHG. 1.54% of the Total Voting Rights (this corresponds to 9,300,191 voting rights) are to be attributed to BlackRock Holdco 2, Inc. pursuant to Sec. 22 para. 1 sentence 1 No. 6 in connection with sentence 2 WpHG. 0.19% of the Total Voting Rights (this corresponds to 1,154,073 voting rights) are to be attributed pursuant to Sec. 22 para. 1 sentence 1 No. 1 WpHG as well as pursuant to Sec. 22 para. 1 sentence 1 No. 6 in connection with sentence 2 WpHG. 3. BlackRock Financial Management, Inc. Section 21, 22 BlackRock Financial Management, Inc., New York, NY, U.S.A., hereby informs you pursuant to Sec. 21 para. 1 WpHG that its share in the voting rights of Bayerische Motoren Werke Aktiengesellschaft (ISIN DE0005190003) on 25 September 2014 amounts to 3.25% (this corresponds to 19,563,585 out of a total of 601,995,196 voting rights (the 'Total Voting Rights')). 1.64% of the Total Voting Rights (this corresponds to 9,855,045 voting rights) are to be attributed to BlackRock Financial Management, Inc. pursuant to Sec. 22 para. 1 sentence 1 No. 1 WpHG. 0.001% of the Total Voting Rights (this corresponds to 5,975 voting rights) are to be attributed to BlackRock Financial Management, Inc. pursuant to Sec. 22 para. 1 sentence 1 No. 2 in connection with sentence 2 WpHG. 0.001% of the Total Voting Rights (this corresponds to 4,892 voting rights) are to be attributed to BlackRock Financial Management, Inc. pursuant to Sec. 22 para. 1 sentence 1 No. 6 WpHG. 1.42% of the Total Voting Rights (this corresponds to 8,549,575 voting rights) are to be attributed to BlackRock Financial Management, Inc. pursuant to Sec. 22 para. 1 sentence 1 No. 6 in connection with sentence 2 WpHG. 0.19% of the Total Voting Rights (this corresponds to 1,154,073 voting rights) are to be attributed pursuant to Sec. 22 para. 1 sentence 1 No. 1 WpHG as well as pursuant to Sec. 22 para. 1 sentence 1 No. 6 in connection with sentence 2 WpHG.' 30.09.2014 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Bayerische Motoren Werke AG Petuelring 130 80788 MÃ¼nchen Germany Internet: www.bmwgroup.com End of Announcement DGAP News-Service ---------------------------------------------------------------------------

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Swanson Nexus Pro Launch: Boost for Dietitians

By Lucas Young Updated Oct 24, 2026 Category News Views 160

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

TORRAS Stands Tall with iPhone 18 Pro Cases

By Riley Hayes Updated Oct 24, 2026 Category News Views 191

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Bio-Thera's New Data: A Game Changer for NSCLC?

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Aluminum Design Fumble: Geometry Over Wall Thickness

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

DIRECTV Bags New NHL Deals: Stakes for Sports Fans

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

What to Expect: Your First Therapy Session Insights

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

DigitalXForce Booms with 514% Growth and Major Backing

Massive Growth and Strategic Investment in DigitalXForce Now here’s a company that’s shaking things up—DigitalXForce. Right on the back of a staggering 514% growth, they’ve corralled a strategic investment from Arsenal Growth Equity. If you blink, you might miss just how fast they’re sprinting through the tech landscape. Institutional Support Backing the...

Likang's Bold Move: Cancer Immunotherapy at AD Summit

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...